Clearside Biomedical Inc reports results for the quarter ended in June - Earnings Summary

Clearside Biomedical,

09/08/2022 14:33

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in June. The
mean expectation of six analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue fell 50.8% to $384.00 thousand from a year ago;
analysts
expected $375.00 thousand. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 22.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearside Biomedical Inc shares had risen by 11.6% this
quarter and lost 40.4% so far this year.
    * The company reported a quarterly loss of $7.81 million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.13          -0.13          Met
 Mar. 31 2022      -0.08          -0.13          Missed
 Dec. 31 2021      0.16           0.31           Beat
 Sep. 30 2021      -0.08          -0.08          Met